Trade Bayer ^BAYGn

China Approves Bayer's Asundexian: A Game-Changer in Stroke Prevention, ETPharma

Bayer banks on new market opportunities in China

Bayer's Asundexian Becomes First Factor XIa Inhibitor Approved In China For Stroke Prevention

Correction to Bayer Update | Morningstar

Bayer Gets China Approval for Stroke-Prevention Drug in Global First for New Class - Update | Morningstar

Bayer Gets in China Its First Global Approval for Stroke Prevention Drug | Morningstar

MNCs tap China for global scale

Bayer announces new data at ESMO 2026 on NUBEQA

Commerce minister Piyush Goyal discusses investment avenues with German companies

Midterms, rift with moms may be 'death knell' of MAHA-Trump alliance

Piyush Goyal discusses investment opportunities with Bayer, Fresenius

Ophthalmology Sector Emerges as Must-Win Battleground for Global Pharma: Eli Lilly, Merck & Co., AbbVie, Innovent Biologics, Hengrui Medicine and Leading Players Enter the Market

Piyush Goyal holds talks with Fresenius, Bayer, Knauf executives to explore deeper India collaboration

Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial

RFK Jr. Adviser Calley Means Quits Amid Food Policy Delays

Rare prostate cancer histologies: detection, characteristics and treatment

Retiring This Year? Here's How To Build an Accurate Monthly Spending Estimate Before Your Last Paycheck - AOL

Closing the gap: disparities in access to and implementation of guideline-directed medical therapy for CKM syndrome

Luke Bryan's Farm Tour Delivers Millions of Meals and FFA Support

McKenzie Lake Lawyers LLP, Merchant Law Group, and Siskinds Desmeules Announce the Settlement of Yasmin and YAZ Class Action Litigation

Bayer partners with Absolute's INERA to expand biological crop nutrition in India - The Economic Times

Vividion Therapeutics Expands Clinical Development of WRN Inhibitor VVD-214 with Phase 2 Combination Study in First-Line Patients with Advanced Colorectal Cancer | Morningstar

Is Bayer (XTRA:BAYN) Undervalued As FDA Accepts KERENDIA Filing?

Switch Bioworks, Bayer Collaborate on Biological Nitrogen Fertilizer | Agri-Pulse Communications, Inc.

Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial

Bayer scales direct seeded rice push as acreage crosses 2 lakh in 2026

Bayer to distribute, market INERA's crop nutrition products

Bayer expands its direct seeded rice program to over 2 lakh acres in 2026

Assessing products to counter side effects of GLP-1, says Bayer's Triana

BAYN: Litigation Is Still Costly, Crop Execution And New Drugs Drive The Upside

Leverkusen keen to extend Maza's contract as Premier League sides circle

Bayer Moves To Expand KERENDIA Into Chronic Kidney Disease Without Diabetes

U.S. FDA Accepts Bayer's Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes | Morningstar

The Contrast Media Market: The Invisible Hand Behind Every Clear Scan

Biopharma building innovation ecosystem

Bayer (XTRA:BAYN) Expands Ohio Pharma Capacity, Is It Still 24% Below Fair Value?

Florian Wirtz suffers biggest market value drop in Premier League

Kofane Delays Leverkusen Deal As Premier League Interest Grows

Bayer (XTRA:BAYN) Could Be 24% Undervalued As $2.2b Ohio Drug Hub Takes Shape

Bayer deepens US manufacturing push with Ohio plant plan

Zydus launches in U.S. MSN Labs generic of Bayer's PAH drug

Zydus and MSN Launch First Generic Alternative of Bayer's Adempas in the US, ETPharma

Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US

Bayer Unveils $2.2 Billion Manufacturing Facility in Ohio to Expand Drug Production, ETPharma

Bayer To Invest $2.2 Bln In Ohio Pharma Site, To Create 2,100 Jobs

Bayer To Invest $2.2 Bln In Ohio Pharma Manufacturing Campus

Germany's Bayer to invest $2.2 billion in US pharma site

BAYN: Legal Progress Helps, Execution Risk Still Drives The Case

Bayer to invest $2.2 B in new manufacturing site in US to create highly-skilled jobs

President Trump grants disaster relief for Ohio after August storms

Bayer to build $2.2 billion pharmaceutical plant in Ohio

Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | Morningstar

Three-year real-world outcomes of faricimab in pretreated eyes with treatment-resistant neovascular age-related macular degeneration

South Korea Cell and Gene Therapy Manufacturing Market Forecast to 2035 | 29.56% CAGR Unlocks a USD 7.54 Billion Opportunity in CDMO Capacity and GMP Expansion

Bayer Promotes Christoph Koenen to Chief Medical Officer | Morningstar

Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

Case: Patents/Eligibility (D. Del.)

Bayer Advances Patent Suit Over Moderna, Pfizer Covid Vaccines

Bayer (XTRA:BAYN) Stock Could Be Undervalued Following FDA Priority Review News

Bayer launches MiraSOFT stool softener exclusively at CVS

Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial

Bayer Gains FDA Priority Review For Lynkuet Label Expansion In Breast Cancer-Related Indication

Bayer: FDA Grants Priority Review To Lynkuet For New Indication

Bayer's Alka-Seltzer Collaborates with Alka Yagnik for Unique Advertising Campaign, ETBrandEquity

Use of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations